[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356444-105":59,"doc-detail-356444-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","single-cell-transcriptomic-profiling-combined-with-mendelian-randomization-illuminates-molecular-drivers-of-bladder-cancer","Single-cell transcriptomic profiling combined with Mendelian randomization illuminates molecular drivers of bladder cancer","","Bladder cancer shows strong cellular heterogeneity, making it difficult to identify molecular drivers that are both functionally relevant and supported by genetics. The study links genetic susceptibility to transcriptional activity by integrating single-cell transcriptomes from bladder carcinoma and adjacent normal tissues with Seurat and Harmony for normalization, integration, and dimensionality reduction. Differentially expressed genes are prioritized using causal inference from GWAS and eQTLs, followed by pathway enrichment, immune profiling, and transcription factor network inference.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-cell-transcriptomic-profiling-combined-with-mendelian-randomization-illuminates-molecular-drivers-of-bladder-cancer/356444/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-cell-transcriptomic-profiling-combined-with-mendelian-randomization-illuminates-molecular-drivers-of-bladder-cancer/356444.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is identifying molecular drivers in bladder cancer challenging?","Question",{"text":113,"@type":114},"Bladder cancer contains marked cellular heterogeneity, which complicates distinguishing drivers with both functional impact and genetic support.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were gene candidates prioritized in this study?",{"text":118,"@type":114},"Differentially expressed genes were prioritized using causal inference based on genome-wide association study (GWAS) data and expression quantitative trait loci (eQTL) data.",{"name":120,"@type":111,"acceptedAnswer":121},"Which genes were highlighted by Mendelian randomization?",{"text":122,"@type":114},"Mendelian randomization identified six bladder-cancer-related genes: ARHGEF18, HLA-DRB5, ISG20, NCF1, RPL13, and YPEL5, with ARHGEF18 increasing risk and YPEL5 showing a protective association.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356444,1790158673,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Molecular Genetics and Genomics (2026) 301:50  \n[https://doi.org/10.1007/s00438-026-02371-w](https://doi.org/10.1007/s00438-026-02371-w)  \nORIGINAL ARTICLE  \nSingle-cell transcriptomic profiling combined with Mendelian randomization illuminates molecular drivers of bladder cancer  \nJunrui He1,6 · Zhuoying Jiang2,8 · Shan Peng3,7 · Lijuan Peng2,8 · Zhongyou Xia4,6 · Ting Ma5 · Xiaojun Tan4,6 · Qiongxian Long2,8 · Ji Wu4,6  \nReceived: 29 July 2025 / Accepted: 26 January 2026 © The Author(s) 2026  \nAbstract  \nBladder cancer exhibits marked cellular heterogeneity, which complicates the identification of molecular drivers with both functional and genetic relevance. The link between genetic susceptibility and transcriptional activity in tumorigenesis remains incompletely understood. Single-cell transcriptomes of bladder carcinoma and adjacent normal tissues were processed using Seurat and Harmony for data normalization, integration, and dimensionality reduction. Differentially expressed genes were further prioritized using causal inference based on genome-wide association and expression quantitative trait loci data. Functional analyses included pathway enrichment, immune profiling, and transcription factor network inference. Candidate genes were validated through immunohistochemistry, quantitative PCR, and Western blotting, and in vitro cell-based assays (including CCK-8, scratch wound healing, transwell invasion, and flow cytometry analysis) . Among all cellular populations, B cells showed the highest fold-change score. Mendelian randomization highlighted six bladder-cancer-related genes—ARHGEF18, HLA-DRB5, ISG20, NCF1, RPL13, and YPEL5 . ARHGEF18 raised risk (OR 1.001; 95% CI 1.000–1.002; P 0.017), whereas YPEL5 showed a protective association (OR 0.997; 95% CI 0.995–0.999; P 0.003) . Immunohistochemistry confirmed elevated ARHGEF18 and reduced YPEL5 expression in tumor tissues. In vitro experiments demonstrated that ARHGEF18 knockdown and YPEL5 overexpression led to decreased cell proliferation, migration, invasion, and increased apoptosis in T24 and 5637 bladder cancer cells. Our findings identify ARHGEF18 and YPEL5 as genetically and transcriptionally supported regulators of bladder cancer, highlighting a scalable strategy for linking genetic risk to cell-type–specific mechanisms.  \nKeywords Bladder cancer · Mendelian randomization · Single-cell transcriptomics · Immune profiling · Immunometabolism  \nCommunicated by Wenfei Jin  \n􀀍 Ji Wu [wuji2168@163.com](wuji2168@163.com)  \n1 Department of Urology, Nanchong Central Hospital Affiliated to North Sichuan Medical College, Nanchong 637000, China  \n2 Department of Pathology, Nanchong Central Hospital Affiliated to North Sichuan Medical College, Nanchong 637000, China  \n3 Department of Medical Rehabilitation, Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital, Nanchong 637000, China  \n4 Department of Urology, Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital, Nanchong 637000, China  \n5 Department of Clinical Medicine, North Sichuan Medical College, Nanchong 637000, China  \n6 Department of Urology, The Second Clinical Medical College of North, Sichuan Medical College, Nanchong 637000, China  \n7 Department of Medical Rehabilitation, The Second Clinical Medical College of North Sichuan Medical College, Nanchong 637000, China  \n8 Department of Pathology, The Second Clinical Medical College of North, Sichuan Medical College, Nanchong 637000, China  \n1 3  \nAbbreviations  \nGWASscRNA-seq MR  \nNCBI  \nSNP  \nMAD  \nUMAP  \nGO  \nIVs  \nIVW  \nLD  \nInSIDE GSEA  \nGSVA  \nNES  \nAUC  \nIHC  \nqPCR  \nWB  \nSD  \nIQR  \nTAMs  \nGenome-wide association studies Single-cell RNA sequencing Mendelian randomization National center for biotechnology information  \nSingle nucleotide polymorphism Median absolute deviation  \nUnified manifold approximation and projection  \nGene ontology Instrumental variables Inverse variance weighted Linkage diseq","cbCainBnm436HWEc","https://ap.wps.com/l/cbCainBnm436HWEc","pdf",3418138,18,"English","# Abstract\n## Methods and analysis\n## Functional validation","[{\"question\":\"Why is identifying molecular drivers in bladder cancer challenging?\",\"answer\":\"Bladder cancer contains marked cellular heterogeneity, which complicates distinguishing drivers with both functional impact and genetic support.\"},{\"question\":\"How were gene candidates prioritized in this study?\",\"answer\":\"Differentially expressed genes were prioritized using causal inference based on genome-wide association study (GWAS) data and expression quantitative trait loci (eQTL) data.\"},{\"question\":\"Which genes were highlighted by Mendelian randomization?\",\"answer\":\"Mendelian randomization identified six bladder-cancer-related genes: ARHGEF18, HLA-DRB5, ISG20, NCF1, RPL13, and YPEL5, with ARHGEF18 increasing risk and YPEL5 showing a protective association.\"}]","Single-cell transcriptomic profiling combined with Mendelian randomization illuminates molecular drivers of bladder cancer | PDF",1790125349,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ed8a3c9deaced90a08baa007a92570a.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ab3a095532771e81c2194cdb80cb807.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8821d894fdb8245e4e2b1b22be7a396.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3dde4e9a2842a8439000efc12c037c3f.webp",980,1301]